DAVI — Davion Healthcare Plc
$2.69-18.24%
Last close: · regular session
After-hours $2.46 -8.55% ·
Last 6 sessions
DAVI closed at $2.69 (-18.24%) on Oct 29, 2026. Float: 13.5M shares. Latest SEC filing: 6-K on Oct 29, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for DAVI in the TickerWise workspace.
Davion Healthcare PLC is focus on developing its range of home tests for a range of home test products, to identify potential medical conditions and provide early warning to enable further clinical examination where applicable. It designs, develops, and patents medical products and non-diagnostic devices and then licenses the manufacturing, marketing, sales, and distribution rights for its products to regional or world-wide commercial partners. The company has been operating as a single segment. Its products are BreastCheck, FootFlow, and Testic.
Company profile
- Sector: Healthcare
- Industry: Surgical & Medical Instruments & Apparatus
- Country: CY
- Exchange: NASDAQ
- Website: https://www.davionhealthcare.com
Latest SEC filings for DAVI
Latest DAVI news
- DAVI Stock Retreats Sharply As Volatility Grabs Traders’ Attention
- DAVI Stock Slides After Parabolic Spike Draws Cautious Traders
- DAVI Stock Slides As Volatility Grips Thinly Traded Healthcare Name
- DAVI Stock Pulls Back Sharply As Volatility Grips Traders
- DAVI Stock Slides As Volatility Grips Davion Healthcare
- Battery-free wound dressing assets go to Davion Healthcare (Nasdaq: DAVI) in a cash-and-stock deal.
- Davion Healthcare acquires Humaskan Medical Technology intellectual property for $25M Read article
- Davion Healthcare Plc (DAVI) Stock Price, News & Analysis
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.